Telehealth & Digital Health

New data reveals upstream patient guidance slashes surgical costs, challenging the old guard of healthcare management and signaling a new era of digital-first care.

A new strategic alliance between a pharma giant and a leading non-profit is deploying a $20M plan to close the deadly prostate cancer survival gap.

As Orca Bio builds a manufacturing empire from Sacramento to Princeton, it's not just preparing for a new drug launch—it's trying to solve the biggest puzzle in biotech.

A 23% national drop in overdose deaths signals progress, but regional disparities and a volatile drug supply show the fight is far from over.

A new partnership between Klick Labs and Mayo Clinic aims to detect disease using your voice. But what does this mean for the future of our health systems?

While CEO Craig Chambliss's EY award makes headlines, the real story is Neurelis's disruption of epilepsy care and its ambitious pipeline for brain disorders.

Legend Biotech's stunning trial results for an 'in vivo' CAR-T therapy could make advanced cancer treatment faster, safer, and accessible to all.

A new data-driven framework aims to move senior living beyond bingo attendance, tackling the silent epidemic of loneliness. But can technology truly measure connection?

With a landmark therapy for Sanfilippo Syndrome nearing the FDA, Spruce adds veteran marketing and finance chiefs. A look at the talent behind the transition.

A new partnership between cliexa and OpiSafe integrates predictive AI with patented workflow tools, promising to reshape opioid stewardship from within the EMR.

An AI named Grace is now collecting hospital bills more effectively and with higher patient satisfaction than humans. Is this the future of service or a step too far?

Elysium Health's new Creatine+ isn't just a supplement; it's a signal of a massive structural shift where human vitality becomes a core economic asset.

Amid new Ebola fears, one biotech's rapid C1 platform promises 15-day biologics, eyeing a $25B market beyond just pandemic response. But can it deliver?

As 250 million people await a drug for lymphatic diseases, Celltaxis appoints a new CEO to drive its promising inflammation-targeting therapy toward the finish line.

A new partnership between AI consultancy Toboggan Labs and research giant Mila aims to solve a critical problem: turning cutting-edge AI into real-world medical tools.

A new digital marketplace lets dentists bid for your business, promising transparency and lower costs. But can this tech disruption solve the dental affordability crisis?

As climate change fuels record dengue outbreaks across Asia, a new six-nation pact aims for 'Zero Deaths.' But can it overcome the gap between innovation and reality?

BMO's new partnership with non-profit GreenShield isn't just another insurance product. It's a strategic move to merge coverage and care, challenging the market.

For 20 years, Montreal's Segal Cancer Centre has quietly built a world-class innovation engine. We dissect its unique model where research, care, and funding converge.

Skanska's massive Karlstad hospital project promises a high-tech future, but can a building solve deep-seated healthcare system challenges like staff shortages?